BUSINESS Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation Friday, March 27, 2026 · novartis pharma ag Advertisement Read Original Article → Related Dispatches [EU] · Jun 28 Crypto News Today: Pepeto Tops $10.3M as Strategy Insiders Sell [EU] · Jun 28 Aave Price Prediction Turns Heads at $3,500 as Pepeto Presale Nears Its Final Stage [EU] · Jun 28 PDMR Notification